Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 706 AL 720

Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis

Li FJ, Shen L, Ji HF.

J Alzheimers Dis. 2012;31(2):253-8. doi: 10.3233/JAD-2012-120349.

Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease

Côté S, Carmichael PH, Verreault R, Lindsay J, Lefebvre J, Laurin D.

Alzheimers Dement. 2012 May;8(3):219-26. doi: 10.1016/j.jalz.2011.03.012.

Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease

Kotze MJ, van Rensburg SJ.

Metab Brain Dis. 2012 Sep;27(3):255-66. doi: 10.1007/s11011-012-9296-8. Epub 2012 Apr 19.

The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment

Tarawneh R, Holtzman DM.

Cold Spring Harb Perspect Med. 2012 May;2(5):a006148. doi: 10.1101/cshperspect.a006148.

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial

Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G.

PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2.

Guidelines for the management of cognitive and behavioral problems in dementia

Sadowsky CH, Galvin JE.

J Am Board Fam Med. 2012 May-Jun;25(3):350-66. doi: 10.3122/jabfm.2012.03.100183.

Zinc diet and Alzheimer's disease: a systematic review

Loef M, von Stillfried N, Walach H.

Nutr Neurosci. 2012 Sep;15(5):2-12. doi: 10.1179/1476830512Y.0000000010. Epub 2012 Apr 3.

Comparison of hippocampal volume measured using magnetic resonance imaging in Alzheimer's disease, vascular dementia, mild cognitive impairment and pseudodementia

Dolek N, Saylisoy S, Ozbabalik D, Adapinar B.

J Int Med Res. 2012;40(2):717-25. doi: 10.1177/147323001204000236.

APOE: a risk factor for multiple disorders

Myers AJ, Nemeroff CB.

Am J Geriatr Psychiatry. 2012 Jul;20(7):545-8. doi: 10.1097/JGP.0b013e318259b9a5.

A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment

Gibbons LE, Carle AC, Mackin RS, Harvey D, Mukherjee S, Insel P, Curtis SM, Mungas D, Crane PK; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):517-27. doi: 10.1007/s11682-012-9176-1.

Copper toxicity in Alzheimer's disease: cognitive loss from ingestion of inorganic copper

Brewer GJ.

J Trace Elem Med Biol. 2012 Jun;26(2-3):89-92. doi: 10.1016/j.jtemb.2012.04.019. Epub 2012 Jun 4.

Evaluating language comprehension in Alzheimer's disease: the use of the Token test

Paula JJ, Bertola L, Nicolato R, Moraes EN, Malloy-Diniz LF.

Arq Neuropsiquiatr. 2012 Jun;70(6):435-40. doi: 10.1590/s0004-282x2012000600010.

[Is it pseudo-dementia? The validation of the Adas-Cog questionnaire in Hungary]

Drótos G, Pákáski M, Papp E, Kálmán J.

Psychiatr Hung. 2012;27(2):82-91.

Evidence for the accumulation of Abeta immunoreactive material in the human brain and in transgenic animal models

Cuello AC, Allard S, Ferretti MT.

Life Sci. 2012 Dec 10;91(23-24):1141-7. doi: 10.1016/j.lfs.2012.05.020. Epub 2012 Jun 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias